Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months

17. November 2026 aktualisiert von: University of Castilla-La Mancha

Effectiveness of the Herreros Urination Stimulation Technique Versus Bladder Catheterization for Urine Sample Collection in Infants Under 6 Months: A Randomized Clinical Trial Protocol

Urinary tract infections are common in infants, but obtaining a reliable urine sample from babies younger than 6 months can be challenging. Bladder catheterization is a commonly used method for collecting urine, although it is an invasive procedure that may cause discomfort.

This randomized, controlled, open-label clinical trial will compare two methods of urine collection in infants younger than 6 months of age who are suspected of having a urinary tract infection and require a urine test. The study will be conducted at Toledo University Hospital in Spain.

Infants will be randomly assigned to one of two groups. The intervention group will undergo the Herreros technique, a non-invasive method that uses gentle tapping over the lower abdomen and circular massage of the lower back to stimulate spontaneous urination. The control group will undergo intermittent bladder catheterization to collect a urine sample.

The main objective is to compare the success of the two methods in obtaining a urine sample. Secondary objectives include comparing the time required to collect urine, sample contamination rates, pain or discomfort experienced by the infants, complications, costs, and parents' or legal guardians' satisfaction with the procedure.

The study aims to provide evidence on the effectiveness, safety, and cost-effectiveness of the Herreros technique compared with bladder catheterization in infants younger than 6 months.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Urinary tract infection (UTI) is a common bacterial infection in childhood. Obtaining reliable urine samples from infants who are not toilet-trained can be challenging. Bladder catheterization is an established method for urine collection, although it is invasive and may cause pain or discomfort. The Herreros urination stimulation technique is a non-invasive alternative based on physical stimulation of spontaneous urination.

This randomized, controlled, open-label clinical trial will be conducted at Toledo University Hospital, Castilla-La Mancha, Spain. The study will compare the Herreros urination stimulation technique with intermittent bladder catheterization for urine collection in infants with suspected UTI.

A minimum of 60 participants is planned, with 30 participants allocated to each study group. Sample size estimation was performed using the GRANMO program, considering expected urine collection success rates of 86% and 100% in the intervention and control groups, respectively, with a two-sided alpha level of 0.05 and statistical power greater than 80%.

Participants will be randomly assigned in a 1:1 ratio using a computer-generated randomization sequence managed by an independent unit coordinator. Due to the nature of the procedures, blinding of healthcare professionals performing the interventions will not be possible. However, laboratory personnel responsible for urine culture analysis and sample contamination assessment will be blinded to group allocation.

Intervention procedures

In the intervention group, urine collection will be attempted using the Herreros technique. The procedure involves feeding the infant approximately 20-30 minutes before the intervention, cleaning the genital area, and alternating gentle suprapubic tapping with circular massage of the lumbar paravertebral region using the thumbs. These maneuvers will be performed for a maximum of five minutes or until spontaneous urination occurs. A midstream urine sample will then be collected in a sterile container.

Non-pharmacological analgesia, including non-nutritive sucking or 2% sucrose solution, may be used in accordance with the study protocol. If urine collection is unsuccessful within five minutes, bladder catheterization will be performed to obtain the required sample, and this circumstance will be documented.

In the control group, urine samples will be obtained through intermittent bladder catheterization performed by qualified healthcare professionals in accordance with the hospital's standard clinical procedures. The time required to complete the procedure will be recorded using a stopwatch.

Data collection and statistical analysis

Study data will be recorded using a standardized data collection form. Statistical analyses will be performed using IBM SPSS Statistics. Categorical data will be expressed as frequencies and percentages, while quantitative data will be summarized using means and standard deviations or appropriate alternative descriptive statistics.

Between-group comparisons will be performed using the chi-square test or Fisher's exact test for categorical variables and Student's t-test or Mann-Whitney U test for quantitative variables, depending on data distribution. Pearson or Spearman correlation analyses and multiple logistic regression will be used, where appropriate, to explore associations between relevant study variables.

Safety monitoring and ethical considerations

Participants will be monitored by the healthcare professionals performing the urine collection procedures. Any complications or adverse events potentially related to either technique will be documented, and appropriate clinical care will be provided. Serious adverse events will be reported to the unit coordinator and principal investigator within 24 hours.

The study will commence only after approval by the relevant Research Ethics Committee and authorization from the participating hospital services. Written informed consent will be obtained from parents or legal guardians before participation. All study data will be handled confidentially in accordance with applicable Spanish data protection legislation and ethical principles governing biomedical research.

Studientyp

Interventionell

Einschreibung (Geschätzt)

60

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

1 Sekunde bis 6 Monate (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Infants of both sexes under 6 months of age (up to 180 days).
  • Infants requiring a urine sample collection for the diagnosis of a suspected urinary tract infection (UTI) prescribed by a physician in the neonatology, pediatrics, or pediatric emergency department.
  • Parents or legal guardians willing and able to sign the informed consent form.

Exclusion Criteria:

  • Infants with prior antibiotic treatment.
  • Infants with a diagnosis of urological or gynecological congenital malformations, severe phimosis, tight labial adhesions in females, genital infection, or complex genital abnormalities.
  • Infants presenting with any skin lesion (such as wounds, burns, trauma, etc.) that could contraindicate or prevent the performance of the Herreros technique and/or urinary catheterization.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Diagnose
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Herreros Bladder Stimulation Group

Infants undergo the non-invasive bladder stimulation technique described by Herreros et al., combining feeding with gentle suprapubic taps and lumbar paravertebral massage to induce spontaneous midstream urine collection.

Infants receive the non-invasive bladder stimulation technique described by Herreros et al. This involves a feeding (breast milk or formula) 20 to 30 minutes prior to the procedure, followed by a maximum of 5 minutes of alternating cycles of gentle suprapubic tapping (using fingertips) and lumbar paravertebral massage (using circular thumb movements). Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is administered during the procedure.

Andere Namen:
  • Bladder stimulation technique Suprapubic tapping and lumbar massage technique
Aktiver Komparator: Urinary Catheterization Group

Infants undergo intermittent urinary catheterization as the reference standard procedure for obtaining a sterile urine sample.

Infants undergo intermittent urinary catheterization as the reference standard procedure. After proper perineal cleansing and the application of sterile lubricant, a pediatric urinary catheter (size 6-8 Fr) is gently inserted through the urethra into the bladder to obtain a sterile urine sample. Non-pharmacological analgesia (such as a pacifier or 2% sucrose) is provided during the procedure.

Andere Namen:
  • Intermittent catheterization, Bladder catheterization

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Successful urine sample collection rate
Zeitfenster: Within 5 minutes (300 seconds) from the start of the procedure

Percentage of infants in each group in whom a sufficient urine sample for urinalysis and urocultivo is successfully obtained within 5 minutes after the start of the procedure.

Within 5 minutes (300 seconds) from the start of the procedure

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Time to urine collection
Zeitfenster: From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).

The total time elapsed (in seconds) from the start of the procedure until the successful collection of the urine sample.

From the start of the urine collection procedure (hand hygiene and glove placement) until a urine sample sufficient for culture is obtained, assessed up to 5 minutes (300 seconds).
Urine sample contamination rate
Zeitfenster: From urine collection until the final urine culture report, assessed up to 72 hours

Percentage of collected urine samples classified as contaminated based on urocultive criteria (such as growth of two or more microorganisms, presence of non-uropathogens, or leukocyturia).

From urine collection until the final urine culture report, assessed up to 72 hours
Parental satisfaction score
Zeitfenster: Immediately after the procedure, before discharge

Evaluation of parents' or legal guardians' satisfaction with the procedure, measured using an ad-hoc survey on a scale. PARENT/GUARDIAN OPINION AND SATISFACTION QUESTIONNAIRE FOR THE INFANT. The minimum score is 0, indicating the worst possible outcome, in which parents/legal guardians are not at all satisfied with the procedure performed on their infant or with the time required to obtain the urine sample. The maximum score is 10, indicating that parents/legal guardians are very satisfied with both the procedure performed and the time required to obtain the urine sample.

Immediately after the procedure, before discharge
Procedure costs
Zeitfenster: During the urine collection procedure (including rescue catheterization, if needed)

Direct economic cost of each procedure based on material resources utilized and healthcare personnel time required per successful sample obtained.

During the urine collection procedure (including rescue catheterization, if needed)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Mitarbeiter

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Dezember 2026

Primärer Abschluss (Geschätzt)

1. Juni 2027

Studienabschluss (Geschätzt)

1. Juni 2027

Studienanmeldedaten

Zuerst eingereicht

30. Oktober 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

17. November 2026

Zuerst gepostet (Tatsächlich)

19. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

19. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

17. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2295

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .